A systems model for immune cell interactions unravels the mechanism of inflammation in human skin.

Najl V Valeyev, Christian Hundhausen, Yoshinori Umezawa, Nikolay V Kotov, Gareth Williams, Alex Clop, Crysanthi Ainali, Christos Ouzounis, Sophia Tsoka, Frank O Nestle
Author Information
  1. Najl V Valeyev: St John's Institute of Dermatology, King's College London, London, United Kingdom. N.Valeyev@kent.ac.uk

Abstract

Inflammation is characterized by altered cytokine levels produced by cell populations in a highly interdependent manner. To elucidate the mechanism of an inflammatory reaction, we have developed a mathematical model for immune cell interactions via the specific, dose-dependent cytokine production rates of cell populations. The model describes the criteria required for normal and pathological immune system responses and suggests that alterations in the cytokine production rates can lead to various stable levels which manifest themselves in different disease phenotypes. The model predicts that pairs of interacting immune cell populations can maintain homeostatic and elevated extracellular cytokine concentration levels, enabling them to operate as an immune system switch. The concept described here is developed in the context of psoriasis, an immune-mediated disease, but it can also offer mechanistic insights into other inflammatory pathologies as it explains how interactions between immune cell populations can lead to disease phenotypes.

References

  1. PLoS Comput Biol. 2008 Apr 25;4(4):e1000014 [PMID: 18437239]
  2. J Theor Biol. 2004 Sep 21;230(2):145-55 [PMID: 15321710]
  3. Thorax. 2008 Jun;63(6):566-8 [PMID: 18511642]
  4. Clin Exp Immunol. 2007 Dec;150(3):407-15 [PMID: 17900301]
  5. Nature. 2009 Jul 9;460(7252):274-7 [PMID: 19536158]
  6. Cell. 2003 Jan 24;112(2):169-80 [PMID: 12553906]
  7. Am J Transplant. 2008 Sep;8(9):1911-20 [PMID: 18786233]
  8. J Theor Biol. 2006 Sep 7;242(1):237-56 [PMID: 16616206]
  9. J Immunol. 2009 Apr 1;182(7):4056-64 [PMID: 19299703]
  10. J Exp Med. 2009 Aug 3;206(8):1755-67 [PMID: 19635862]
  11. Am J Hum Genet. 2007 Sep;81(3):559-75 [PMID: 17701901]
  12. J Pediatr Surg. 2007 Mar;42(3):445-53 [PMID: 17336179]
  13. Curr Drug Targets Inflamm Allergy. 2004 Jun;3(2):121-8 [PMID: 15180464]
  14. Nat Genet. 2009 Feb;41(2):199-204 [PMID: 19169254]
  15. N Engl J Med. 2009 Jul 30;361(5):496-509 [PMID: 19641206]
  16. J Exp Med. 2009 Aug 31;206(9):1853-62 [PMID: 19667061]
  17. Shock. 2008 Jan;29(1):104-11 [PMID: 18157069]
  18. PLoS One. 2010 Apr 19;5(4):e10066 [PMID: 20419099]
  19. Trends Immunol. 2007 Feb;28(2):51-7 [PMID: 17197238]
  20. J Invest Dermatol. 2009 Jun;129(6):1339-50 [PMID: 19322214]
  21. J Immunol. 2010 Mar 24;184(9):5263-5270 [PMID: 20335534]
  22. Nat Immunol. 2007 Sep;8(9):967-74 [PMID: 17581537]
  23. PLoS Comput Biol. 2009 Apr;5(4):e1000362 [PMID: 19390606]
  24. J Theor Biol. 2006 Sep 7;242(1):220-36 [PMID: 16584750]
  25. J Exp Med. 2004 Mar 1;199(5):731-6 [PMID: 14981113]
  26. Mediators Inflamm. 2005 Oct 24;2005(5):273-9 [PMID: 16258194]
  27. Endocr Rev. 1985 Winter;6(1):45-86 [PMID: 3884329]
  28. J Invest Dermatol. 2009 Sep;129(9):2175-83 [PMID: 19295614]
  29. Mol Syst Biol. 2009;5:293 [PMID: 19638974]
  30. Mol Med. 2006 Apr-Jun;12(4-6):88-96 [PMID: 16953560]
  31. Immunology. 2005 May;115(1):21-33 [PMID: 15819694]
  32. Cancer Control. 2009 Apr;16(2):141-52 [PMID: 19337200]
  33. Hum Genet. 2007 Sep;122(2):201-6 [PMID: 17587057]
  34. J Invest Dermatol. 2006 May;126(5):1043-51 [PMID: 16484990]
  35. Cardiol Rev. 2008 Nov-Dec;16(6):273-9 [PMID: 18923230]
  36. Inflamm Bowel Dis. 2009 Jun;15(6):883-9 [PMID: 19235914]
  37. Curr Mol Med. 2004 Nov;4(7):753-62 [PMID: 15579022]
  38. Annu Rev Physiol. 2009;71:489-507 [PMID: 19575684]
  39. Adv Exp Med Biol. 2008;640:312-24 [PMID: 19065799]
  40. Clin Dermatol. 2007 Nov-Dec;25(6):568-73 [PMID: 18021894]
  41. Clin Rev Allergy Immunol. 2007 Oct;33(1-2):45-56 [PMID: 18094946]
  42. Immunol Res. 2006;36(1-3):237-45 [PMID: 17337784]
  43. Math Biosci. 2009 Jan;217(1):1-10 [PMID: 18835282]
  44. Curr Med Chem. 2004 Feb;11(4):447-64 [PMID: 14965226]
  45. Shock. 2009 Aug;32(2):172-8 [PMID: 19008782]
  46. Int Immunol. 2005 May;17(5):649-59 [PMID: 15837713]
  47. Br J Dermatol. 2001 Apr;144(4):849-53 [PMID: 11298547]
  48. J Immunol. 2010 Jan 15;184(2):624-36 [PMID: 20007530]
  49. Genes Immun. 2007 Jan;8(1):1-12 [PMID: 17093502]
  50. Curr Opin Crit Care. 2004 Oct;10(5):383-90 [PMID: 15385756]
  51. PLoS Med. 2007 May;4(5):e177 [PMID: 17518516]
  52. Nat Rev Immunol. 2009 May;9(5):313-23 [PMID: 19343057]
  53. Diabetologia. 1985 Jul;28(7):412-9 [PMID: 3899825]
  54. Br J Dermatol. 2005 Jun;152(6):1211-8 [PMID: 15948984]
  55. Ann N Y Acad Sci. 2002 Jun;966:xiii-xviii [PMID: 12114252]
  56. Wound Repair Regen. 2010 Jan-Feb;18(1):1-2 [PMID: 20082673]

Grants

  1. /Wellcome Trust
  2. G0601387/Medical Research Council

MeSH Term

Cytokines
Dose-Response Relationship, Immunologic
Gene Expression Profiling
Genome-Wide Association Study
Histocytochemistry
Homeostasis
Humans
Inflammation
Leukocytes
Models, Biological
Phenotype
Psoriasis
Signal Transduction
Skin
Systems Biology

Chemicals

Cytokines

Word Cloud

Created with Highcharts 10.0.0cellimmunecytokinepopulationsmodelcanlevelsinteractionsdiseasemechanisminflammatorydevelopedproductionratessystemleadphenotypesInflammationcharacterizedalteredproducedhighlyinterdependentmannerelucidatereactionmathematicalviaspecificdose-dependentdescribescriteriarequirednormalpathologicalresponsessuggestsalterationsvariousstablemanifestdifferentpredictspairsinteractingmaintainhomeostaticelevatedextracellularconcentrationenablingoperateswitchconceptdescribedcontextpsoriasisimmune-mediatedalsooffermechanisticinsightspathologiesexplainssystemsunravelsinflammationhumanskin

Similar Articles

Cited By